Wall Street banks net record fees, Johnson channels FDR, remdesivir cost

episode

FT News Briefing not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from FT News Briefing

How a Russian forgery scheme evaded sanctions 11 min · 22 Sep 2026

Germany’s Merz vows to stay despite ‘disaster’ 12 min · 21 Sep 2026

Reform UK mega-donors stir controversy 13 min · 18 Sep 2026

Fed interest rate rises are back 12 min · 17 Sep 2026

US billionaires bankroll Republican election push 11 min · 16 Sep 2026

What an AI slowdown could mean for investors 12 min · 15 Sep 2026

All episodes from FT News Briefing →

Report any issue

Source

Recorded30 Jun 2020

Publisherrss.acast.com ↗

Handlerec:496108

Show notes

Wall Street investment banks brought in a record amount of fees for fundraisings in the first six months of 2020 amid coronavirus, UK prime minister Boris Johnson plans to announce £5bn of infrastructure projects today, and Gilead Sciences has said it will charge governments $2,340 for a 5-day course of its coronavirus treatment, remdesivir. Plus, the FT’s Primrose Riordan explains why investors, economists, and analysts are growing concerned over China’s national security law in Hong Kong. Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in